你好,欢迎访问上海交通大学附属第一人民医院公济文库!
所在位置: 首页 - 科室团队导航 - 肿瘤临床医学中心
相关导航
按语种分组
  • 任何
  • 413 中文
  • 372 外文
年代
  • 任何
  • 49 2021
  • 90 2020
  • 60 2019
  • 63 2018
  • 58 2017
  • 45 2016
  • 35 2015
  • 34 2014
  • 18 2013
  • 22 2012
  • 34 2011
  • 18 2010
  • 214 2000-2009
  • 41 1990-1999
按类型分组
  • 任何
  • 366 中文期刊
  • 362 外文期刊
  • 27 中文会议论文
  • 18 中文专利
  • 9 外文专利
  • 更多
按重要期刊分组
  • 任何
  • 315 SCI科学引文索引(美)
  • 261 国内统计源期刊
  • 250 SCIE
  • 213 CSCD中国科学引文库
  • 181 CA化学文摘(美)
  • 更多
按来源刊物分组
  • 任何
  • 23 中国癌症杂志
  • 17 肿瘤
  • 16 中华眼科杂志
  • 13 现代生物医学进展
  • 12 Annals of Onc
  • 更多
科室简介: 成果数量:785

上海交通大学附属第一人民医院肿瘤科是上海市三甲综合医院中最早设立的肿瘤专科,是医院“十二五”期间重点发展的学科之一。2009年,医院整合肿瘤相关学科资源,成立了肿瘤中心,学科带头人黄倩教授,中心主任王理伟教授,肿瘤中心副主任王红霞(兼肿瘤科副主任[主持,南])、刘勇副主任医师,北部执行主任李琦主任医... [详细]

本科室知名学者:
本科室科研趋势: 发文数量 期刊收录
条数据
导出

作者: Chao, J.-S.;Zhao, S.-L.;Ou-Yang, S.-W.;Qian, Y.-B.;Liu, A.-Q.;Tang, H.-M.;Zhong, L.;Peng, Z.-H.;Xu, J.-M.;Sun, H.-C. (a Department of General Surgery, Shanghai Organ Transplantat Medical Center, Shanghai General Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai, 200080, China; b Department of Colorectal Surgery, Fudan University, Shanghai Cancer Center, Shanghai, 200032, China; c Division of Critical Care, Department of Liver Surgery, Renji Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai, 200127, China; d Department of Radiology, Shanghai General Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai, 200080, China; e Department of Pathology, Shanghai General Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai, 200080, China)

出处: World Journal of Gastroenterology 2019 Vol.25 No.37 P5630-5640

关键词: Infection;Liver cancer;Liver transplantation;Survival;Tumor recurrence

摘要: BACKGROUND Tumor recurrence after orthotopic liver transplantation (OLT) remains a serious threat for long-term survival of the recipients with hepato ...

作者: Cheng, J.;He, S.;Wang, M.;Zhou, L.;Zhang, Z.;Feng, X.;Yu, Y.;Ma, J.;Dai, C.;Zhang, S.;Sun, L.;Gong, Y.;Wang, Y.;Zhao, M.;Luo, Y.;Liu, X.;Tian, L.;Li, C.;Huang, Q. (a Molecular Diagnostic Laboratory of Cancer Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 650 Xinsongjiang Road, Songjiang District, Shanghai, 201620, China; b Department of Pathology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; c Department of General Surgery, Shanghai Fourth People\'s Hospital, Shanghai, China; d Department of Pharmacy, First Affiliated Hospital, School of Medicine, Soochow University, Suzhou, China; e Institute of Translational Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; f Department of Dermatology, Duke University Medical Center, Box 3135, Durham, NC 27710, United States)

出处: Clinical Cancer Research 2019 Vol.25 No.12 P3732-3743

摘要: Purpose: Tumor repopulation is known as a major cause of treatment failure and/or tumor recurrence after radiotherapy. The underlying mechanism remain ...

作者: Yao, Z.;Zheng, Z.;Ke, W.;Wang, R.;Mu, X.;Sun, F.;Wang, X.;Garg, S.;Shi, W.;He, Y.;Liu, Z. (a Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 100 Haining Road, Shanghai, 200080, China; b Department of Radiation Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia, PA, United States; c Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 100 Haining Road, Shanghai, 200080, China)

出处: Journal of Translational Medicine 2019 Vol.17 No.1

关键词: Bladder cancer;Brain metastasis;Machine learning;Nomogram;Overall survival

摘要: Background: This study aimed to establish and validate a nomogram for predicting brain metastasis in patients with bladder cancer (BCa) and assess var ...

作者: Wang, Y.;Zhao, M.;He, S.;Luo, Y.;Zhao, Y.;Cheng, J.;Gong, Y.;Xie, J.;Wang, Y.;Hu, B.;Tian, L.;Liu, X.;Li, C.;Huang, Q. (a Cancer Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 650 Xinsongjiang Road, Songjiang District, Shanghai, 201620, China; b Institute of Translational Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; c Department of Dermatology, Duke University Medical Center, Box 3135, Durham, NC 27710, United States)

出处: Journal of Experimental and Clinical Cancer Research 2019 Vol.38 No.1

关键词: Necroptosis;Radiotherapy;RIP1/RIP3/MLKL/JNK/IL-8 pathway;Tumor repopulation

摘要: Background: Tumor cell repopulation after radiotherapy is a major cause for the tumor radioresistance and recurrence. This study aims to investigate t ...

作者: Jiang, Ying;Lin, Jun;Zhang, Jing;Lu, Shasha;Wang, Chun;Tong, Yin (1 Department of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 100 Haining Road, Shanghai, 200080, China 2 Department of Pathology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 100 Haining Road, Shanghai, 200080, China 3 Department of Integrated Therapy, Fudan University Shanghai Cancer Center, 270 Dongan Road, Shanghai, 200032, China 4 Department of Oncology, Shanghai Medical College, Fudan University, 138 Yi xue yuan Road, Shanghai, 200032, China 5 Department of Hematology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, 160 Pujian Road, Shanghai 200127, China)

出处: Pathology - Research & Practice 2019 Vol.215 No.12 P152684

关键词: B7-H1;B7-H4;DLBCL;EBV;Epstein-Barr positive diffuse large B-cell lymphoma

摘要: B7-H4 and B7-H1 are expressed in tumor tissues of 13 patients with EBV+DLBCL. • There is a negative relationship between B7-H4 and B7-H1 in EBV+DLBCL. ...

作者: (AUTHOR) (AUTHOR) (AUTHOR) (AUTHOR) (AUTHOR) (AUTHOR) (AUTHOR) (AUTHOR) (1 Department of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 100 Haining Road, 200080, Shanghai, People\'s Republic of China 2 Department of Hematology, JinHua Hospital of TCM, 439 Shuangxi West Road, 321017, Jinhua, People\'s Republic of China 3 Department of Pathology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 100 Haining Road, 200080, Shanghai, People\'s Republic of China 4 Department of Integrated Therapy, Fudan University Shanghai Cancer Center, 270 Dongan Road, 200032, Shanghai, People\'s Republic of China)

出处: Infectious Agents & Cancer 2019 Vol.14 No.1

关键词: Apoptosis;B7-H4;Epstein-Barr virus positive diffuse large B cell lymphoma

摘要: Background: B7-H4 is among the B7 family members which may serve as a new targetable immune checkpoint molecule. It was reported that high level of se ...

作者: Li, J.;Fu, Q.;Liang, Y.;Cheng, B.;Li, X. (a Department of Orthopedics, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, 200072, China; b Department of Orthopedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China; c Shanghai Concord Medical Cancer Center, Shanghai, 200020, China; d Department of Orthopedics, Changhai Hospital, Naval Military Medical University, Shanghai, 200433, China)

出处: Journal of Molecular Modeling 2019 Vol.25 No.5

关键词: Allosteric pathway;Allostery;Conformational dynamics;Phosphorylation;Primed substrates

摘要: Glycogen synthase kinase 3β (GSK3β), a serine/threonine protein kinase, is involved in several human diseases, including type II diabetes, mood disord ...

作者: Song C;Han Y;Luo H;Qin Z;Chen Z;Liu Y;Lu S;Sun H;Zhou C (Department of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, China Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China Department of Neurology, Fifth Affiliated Hospital of Zheng Zhou University, Zhengzhou, China Department of Pathology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China)

出处: Cancer Medicine 2019 Vol.8 No.12 P5651-5661

关键词: BCL2;HOXA10;apoptosis;gastric cancer;proliferation

摘要: Homeobox A10 (HOXA10) has been implicated critical for the promotion of carcinogenesis, but the underlying mechanism between HOXA10 and malignant gast ...

作者: Fu, Qiang;Xu, Le;Wang, Yiwei;Jiang, Qi;Liu, Zheng;Zhang, Junyu;Zhou, Quan;Zeng, Han;Tong, Shanyou;Wang, Tao;Qi, Yangyang;Hu, Baoying;Fu, Hangcheng;Xie, Huyang;Zhou, Lin;Chang, Yuan;Zhu, Yu;Dai, Bo;Zhang, Weijuan;Xu, Jiejie (1 Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China 2 Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China 3 Department of Urology, Ninth People\'\'s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China 4 Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China 5 Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China 6 Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China)

出处: European Urology 2019 Vol.75 No.5 P752-763

关键词: Clear cell renal cell carcinoma;Glutamine metabolism;Immunotherapy;Interleukin-23;Regulatory T cells;Tumor-associated macrophages

摘要: Background Glutamine addiction is a hallmark of clear cell renal cell carcinoma (ccRCC); yet whether glutamine metabolism impacts local immune surveil ...

作者: Jiang, Yang 1,2,+;Zhou, Jinpeng 1,+;Hou, Dianqi 2;Luo, Peng 1;Gao, Huiling 3;Ma, Yanju 4;Chen, Yin-Sheng 5;Li, Long 1;Zou, Dan 7;Zhang, Haiying 6;Zhang, Ye *,7;Jing, Zhitao *,1 (Affiliations 1 Department of Neurosurgery, The First Hospital of China Medical University, Shenyang City, PR China. 2 Department of Neurosurgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China. 3 College of Life and Health Sciences, Northeastern University, Shenyang, PR China. 4 Department of Medical Oncology, Cancer Hospital of China Medical University, Shenyang, PR China. 5 Department of Neurosurgery/Neuro-oncology, SunYat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, PR China. 6 The First laboratory of cancer institute, the First Hospital of China Medical University, Shenyang City, PR China. 7 International Education College, Liaoning University of Traditional Chinese Medicine, Shenyang City, PR China.)

出处: The Journal of Pathology 2019 Vol.249 No.1 P26-38

关键词: PSAP;glioblastoma;mesenchymal subtype;invasion;EMT.

摘要: Mesenchymal glioblastoma (GBM) is the most aggressive subtype of GBM. Our previous study found that neurotrophic factor prosaposin (PSAP) is highly ex ...

肿瘤临床医学中心简介

上海交通大学附属第一人民医院肿瘤科是上海市三甲综合医院中最早设立的肿瘤专科,是医院“十二五”期间重点发展的学科之一。2009年,医院整合肿瘤相关学科资源,成立了肿瘤中心,学科带头人黄倩教授,中心主任王理伟教授,肿瘤中心副主任王红霞(兼肿瘤科副主任[主持,南])、刘勇副主任医师,北部执行主任李琦主任医师。目前,肿瘤中心下设肿瘤内科、肿瘤放疗科、肿瘤介入科、肿瘤基因诊断及生物治疗科。目前肿瘤中心核定床位数185张,科室现有医技人员共50人,其中医生36人,正高级职称7人,副高级职称9人,中级职称18人,具有博士学历11人,硕士学历18人,博士研究生导师3人,硕士研究生导师5人;5人曾在国外进修学习,2人目前正在国外学习。肿瘤中心现为中国抗癌协会临床肿瘤学会(CSCO)执行委员会单位,CSCO胰腺癌专家委员会主任委员单位、CSCO抗肿瘤药物安全管理委员会委员单位、上海市抗癌协会理事单位、上海市医学会肿瘤专科委员会副主任委员单位、上海市肿瘤放射治疗专业委员会委员单位、上海市肿瘤化疗质控中心专家委员单位、上海市肿瘤放疗质控专家委员会单位。
2013年,经全院肿瘤相关专科共同努力,肿瘤中心入选国家临床重点专科建设项目,建设经费500万元。近3年,获得国家级课题(含国家自然科学基金重大研究计划、国家“973”“863”计划、重大国际合作)17项(仅2015年获得国家自然科学基金9项)、市级课题10项,各类科研经费2500余万元。在《Nature Medicine》、《Gastroenterology》等杂志发表高质量SCI论文。在胰腺癌的基础研究与临床诊治方面在上海市乃至全国颇具影响,主持编写了《胰腺癌患者健康教育手册》、中国首部《胰腺癌综合诊治中国专家共识》,为上海市胰腺疾病重点实验室及上海交通大学胰腺癌诊治中心。在人才培养方面,1人入选国家杰出青年基金计划、1人入选“百千万人才工程”国家级人选、1人入选上海市医学领军人才、1人入选上海市优秀学科带头人计划、3人入选上海市“浦江人才计划”。
2013年成立了肿瘤诊治中心以来,肿瘤学科得到迅猛发展。中心集肿瘤预防、诊断、综合治疗和康复为一体,能开展各项专科项目并形成如下医疗特色:
1.肿瘤个体化化疗、靶向治疗、免疫治疗:根据每位患者独特的基因表达情况,制定个体化的化疗方案,联合靶向治疗,极大提高了结直肠癌、肺癌、乳腺癌、胃癌等治疗效果。
2.精准放疗:目前拥有直线加速器3台,其中包括最先进的VARIAN-RapidArc治疗系统,实现了对实体肿瘤的精准放疗。现已开展三维适形放射治疗、调强适形放射治疗、图像引导下的三维适形调强放疗、同步放化疗、PET-CT引导下放疗、立体定向放射治疗等。
3.肿瘤微创治疗:在上海市开展了首例纳米刀治疗局部晚期胰腺癌,还包括高强度超声聚焦治疗系统(HIFU刀)、射频/微波肿瘤消融治疗系统、高频热疗系统、放射性粒子组织间植入治疗系统、氩氦刀低温冷冻肿瘤治疗系统、血管介入等技术,适用于治疗肝癌、肺癌等实体肿瘤。
4.肿瘤分子诊断:包括免疫功能检测、EGFR、K-ras、BRAF等基因突变检测,Her-2基因扩增检测,循环血肿瘤细胞检测等,为肿瘤患者个体化治疗与靶向治疗选择,以及预后判断,提供了更准确的方法。
5.开设肿瘤多学科联合诊治:多学科、多专家共同参与,为患者制定个体化、综合治疗方案,实现对每位肿瘤患者的全称管理,为肿瘤患者提供最科学的诊断治疗技术和最优质的一站式服务。
6.肿瘤生物治疗:全国率先开展生物免疫治疗与现有传统治疗手段(化疗、放疗)综合治疗实体肿瘤(胰腺癌、乳腺癌等),开展单病种肿瘤生物免疫治疗临床研究多项,通过规范病例入组,规范细胞制备与使用,规范疗效评价,并建立相应的疗效评估体系及规范。
7.新药临床研究:在医院药物临床研究机构的监督下,牵头、参与国际多中心临床研究,为结直肠癌、胰腺癌、乳腺癌、胃癌、肺癌等患者提供最新的药物治疗。
8.中心静脉置管及护理: 1999年我科成功置入上海市第一根PICC导管,开创了护士进 行中心静脉置管的新篇章。2006年引入PORT技术,2007年在全国率先开展非超声引导下塞丁格(MST)穿刺技术,2009年引入B超引导下置管技术,新技术的引进提高了PICC置管成功率,解决了临床实际问题。
目前,肿瘤中心的主要研究方向有:胰腺癌的临床及基础研究、胰腺癌炎-癌转化的基础研究、乳腺癌的基础与临床转化研究、三阴性乳腺癌的精准与免疫治疗研究、肿瘤放疗后再增殖研究、肺癌基础研究、转录因子对肝癌发生发展影响的机制研究、基因多态性与化疗敏感性的临床研究、血药浓度检测与化疗敏感性的临床研究等。"